Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study (Q34550014)

3 August 2017

title

Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study (English)

1 reference

ORCID Public Data File 2021

3 August 2017

0 references

hepatic encephalopathy

1 reference

1 reference

1 reference

author name string

Fernando Gomes Romeiro

1

1 reference

3 August 2017

Fabio da Silva Yamashiro

2

1 reference

3 August 2017

Madileine Francely Américo

3

1 reference

3 August 2017

Luciana Aparecida Corá

4

1 reference

3 August 2017

Giovanni Faria Silva

5

1 reference

3 August 2017

José Ricardo de Arruda Miranda

6

1 reference

3 August 2017

Carlos Antonio Caramori

7

1 reference

3 August 2017

publication date

16 January 2013

1 reference

3 August 2017

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

page(s)

13

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

copyright license

start time

16 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-230x-13-13

0 references

cites work

The role of intestinal endotoxin in liver injury: a long and evolving history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Mechanisms, diagnosis and management of hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Current trends in the treatment of hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

The treatment of hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Review article: the current pharmacological therapies for hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Review article: the burden of hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Management of complications of cirrhosis in patients awaiting liver transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Neostigmine for the treatment of acute hepatic encephalopathy with acute intestinal pseudo-obstruction in a cirrhotic patient

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Plasma and salivary concentrations of erythromycin after administration of three different formulations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

The Role of Endotoxin in Liver Injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

Acquired (non-Wilsonian) hepatocerebral degeneration: complex management decisions.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Review article: erythromycin as a prokinetic agent in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Mechanisms underlying feed intolerance in the critically ill: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Relationship between clock and star drawing and the degree of hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

21 January 2018

Drug therapy: rifaximin

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-13

The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551652

[Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state]

27 October 2018

1 reference

12 December 2020

Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection?

1 reference

12 December 2020

The role of the small intestine in ammonia production after gastric blood administration

1 reference

12 December 2020

Blood ammonia level in liver cirrhosis: a conditio sine qua non to confirm hepatic encephalopathy?

1 reference

12 December 2020

Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-13-13

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference